Sana Kliniken AG

Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma (2015) Becker J, May A, Gerges C, Anders M, Veits L, Weise K, Czamara D, et al. Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) Fasching P, Jud S, Hauschild M, Kuemmel S, Schuette M, Warm M, Hanf V, et al. Journal article A histopathologic and immunohistochemical study on liquification of human adipose tissue ex vivo (2014) Huebner NF, Horch RE, Polykandriotis E, Rau T, Dragu A Journal article PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014) Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al. Journal article Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma (2014) Loibl S, Volz C, Mau C, Blohmer JU, Costa SD, Eidtmann H, Fasching P, et al. Journal article Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44) (2014) Gerber B, Von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, et al. Journal article Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014) Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al. Journal article Vital staining of blood vessels and bile ducts with carboxyfluorescein diacetate succinimidyl ester: A novel tool for isolation of cholangiocytes (2013) Pryymachuk G, Polykandriotis E, Schievenbusch S, Arkudas A, Nierhoff D, Curth HM, Odenthal M, et al. Journal article Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: An entity of concern in the ProGERD study (2012) Leodolter A, Nocon M, Vieth M, Lind T, Jaspersen D, Richter K, Willich S, et al. Journal article